Invivo Therapeutics Holdings (NVIVQ)
OTHER OTC:NVIVQ
US Market
Holding NVIVQ?
Track your performance easily

Invivo Therapeutics Holdings (NVIVQ) Income Statement

510 Followers

Invivo Therapeutics Holdings Income Statement

Last quarter (Q ), Invivo Therapeutics Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Invivo Therapeutics Holdings's net income was $-2.70M. See Invivo Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
---$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 4.95M$ 10.65M$ 9.90M$ 9.10M$ 11.50M$ 12.77M
Operating Income
$ -9.86M$ -10.65M$ -9.90M$ -9.10M$ -11.50M$ -12.77M
Net Non Operating Interest Income Expense
$ 528.00K$ 151.00K$ 3.00K$ 19.00K$ 254.00K$ 206.00K
Other Income Expense
$ -1.00K$ -9.00K$ -2.00K$ 4.00K$ -587.00K$ -10.86M
Pretax Income
$ -9.33M$ -10.49M$ -9.89M$ -9.07M$ -11.83M$ -23.42M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -9.33M$ -10.49M$ -9.89M$ -9.07M$ -11.83M$ -23.42M
Basic EPS
$ -3.28$ -6.83-$ -32.75$ -35.28$ -140.81
Diluted EPS
$ -3.28$ -6.83$ -7.50$ -32.75$ -35.28$ -140.81
Basic Average Shares
$ 10.48M$ 1.54M$ 1.32M$ 276.11K$ 335.35K$ 166.35K
Diluted Average Shares
$ 10.48M$ 1.54M$ 1.32M$ 276.11K$ 335.35K$ 166.35K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 4.95M$ 10.65M$ 9.90M$ 9.10M$ 11.50M$ 12.77M
Net Income From Continuing And Discontinued Operation
$ -9.29M$ -10.50M$ -9.89M$ -9.07M$ -11.83M$ -23.42M
Normalized Income
$ -2.24M$ -8.29M-$ -9.07M$ -11.16M$ -11.26M
Interest Expense
------
EBIT
$ -9.55M$ -10.65M$ -9.89M$ -9.10M$ -11.50M$ -12.77M
EBITDA
$ -9.13M$ -10.21M$ -9.52M$ -8.77M$ -11.18M$ -12.68M
Currency in USD

Invivo Therapeutics Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis